Concepedia

Protein kinase inhibitors of the quinazoline class exert anti-cytomegaloviral activity in vitro and in vivo

Mark R. Schleiss, Jan Eickhoff, Sabrina Auerochs, Martina Leis, S. Abele, Sabine Rechter, Yeon Su Choi, Jodi Anderson, Gillian Scott, William D. Rawlinson,

Antiviral Research · 2008 · 82 citations · 35 references

DOI

Concepts

References

35

BindingDB Entry 50022499: ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy.

PubMed · 2025 · 933 citations · Full text

, , +12

FDA Drug Approval Summary: Gefitinib (ZD1839) (Iressa®) Tablets

Martin H. Cohen, Grant A. Williams, Rajeshwari Sridhara et al. · The Oncologist · 2003 · 577 citations · Full text

, , +10

Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus

Xin Wang, Shu-Mei Huong, Marie L. Chiu et al. · Nature · 2003 · 422 citations

, , +11

Potent and Selective Inhibition of Human Cytomegalovirus Replication by 1263W94, a Benzimidazole <scp>l</scp> -Riboside with a Unique Mode of Action

Karen K. Biron, Stanley C. Chamberlain, Steven S. Good et al. · Antimicrobial Agents and Chemotherapy · 2002 · 364 citations · Full text

, , +17

Cellular Targets of Gefitinib

Dirk Brehmer, Zoltán Greff, Klaus Godl et al. · Cancer Research · 2005 · 239 citations · Full text

, , +16